Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Discovery of BMS-986339, a pharmacologically differentiated farnesoid X receptor agonist for the treatment of nonalcoholic steatohepatitis
Promotes Normal Detoxification*
NOTICE: All information provided above is strictly intended for educational and informational purposes
Buddhala C, Campbell MC, Perlmutter JS, Kotzbauer PT (2015) Correlation between decreased CSF -synuclein and A 1-42 in Parkinson disease
Exploratory endpoints included achieving 15% and 20% weight loss, and patient-reported outcomes assessed using the SF-36 v2.0 and the Three-Factor Eating Questionnaire (TFEQ-R18 v2)
US$ 28.40
US$ 29.54
US$ 21.86
US$ 29.38
US$ 29.84
US$ 22.85
US$ 20.73
